<DOC>
	<DOCNO>NCT00225355</DOCNO>
	<brief_summary>We wish see drug rosiglitazone , currently use treatment type 2 diabetes , could use new treatment angina compare placebo overweight subject overt diabetes . The drug give 3 month subject angina test , way exercise testing , angina quality life questionnaire 24-hour ECG monitoring use drug .</brief_summary>
	<brief_title>Rosiglitazone Versus Placebo Chronic Stable Angina</brief_title>
	<detailed_description>Chronic stable angina common manifestation ischaemic heart disease . Current mechanical therapy ( percutaneous coronary intervention coronary artery bypass graft ) pharmacological therapy ( nitrate , calcium channel blocker , betablockers potassium channel activator ) main action treat end product ischaemic heart disease chronic stable angina , i.e . flow limit stenosis . We postulate treat insulin resistance , upstream factor pathogenesis ischaemic heart disease , improve angina turn improve endothelial function . We attempt demonstrate way full bruce protocol exercise tolerance test , Seattle Angina Questionnaire 24 hour ST segment analysis treatment insulin sensitiser rosiglitazone three month .</detailed_description>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>Chronic stable angina see improve Previous positive exercise tolerance test ensure repeat yield result Disease suitable coronary intervention ( Coronary artery bypass graft angioplasty ) best routine care withheld Do overt diabetes work undertaken elsewhere Body mass index ( BMI ) great 25 Diabetes mellitus see Liver failure ( ALT &gt; 70U/l , AST &gt; 80U/l ) Renal failure ( creatinine &gt; 130mmol/l ) Cardiac failure rosiglitazone contraindicate NYHA 3 4 cardiac failure Physical disability precludes treadmill test Women child bear capacity Breast feeding mother</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Angina pectoris</keyword>
	<keyword>Metabolic syndrome</keyword>
	<keyword>Ischaemic heart disease</keyword>
</DOC>